TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis
Open Access
- 15 April 2020
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 201 (8), 946-954
- https://doi.org/10.1164/rccm.201908-1641oc
Abstract
Rationale: Enhancing non–CFTR (cystic fibrosis transmembrane conductance regulator)-mediated anion secretion is an attractive therapeutic approach for the treatment of cystic fibrosis (CF) and other mucoobstructive diseases. Objectives: To determine the effects of TMEM16A potentiation on epithelial fluid secretion and mucociliary clearance. Methods: The effects of a novel low-molecular-weight TMEM16A potentiator (ETX001) were evaluated in human cell and animal models of airway epithelial function and mucus transport. Measurements and Main Results: Potentiating the activity of TMEM16A with ETX001 increased the Ca2+-activated Cl− channel activity and anion secretion in human bronchial epithelial (HBE) cells from patients with CF without impacting calcium signaling. ETX001 rapidly increased fluid secretion and airway surface liquid height in CF-HBE cells under both static conditions and conditions designed to mimic the shear stress associated with tidal breathing. In ovine models of mucus clearance (tracheal mucus velocity and mucociliary clearance), inhaled ETX001 was able to accelerate clearance both when CFTR function was reduced by administration of a pharmacological blocker and when CFTR was fully functional. Conclusions: Enhancing the activity of TMEM16A increases epithelial fluid secretion and enhances mucus clearance independent of CFTR function. TMEM16A potentiation is a novel approach for the treatment of patients with CF and non-CF mucoobstructive diseases.Keywords
This publication has 43 references indexed in Scilit:
- Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contractionProceedings of the National Academy of Sciences of the United States of America, 2012
- Small‐molecule activators of TMEM16A, a calcium‐activated chloride channel, stimulate epithelial chloride secretion and intestinal contractionThe FASEB Journal, 2011
- TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial CellsPublished by Elsevier BV ,2011
- Purinergic receptors in airway epitheliaCurrent Opinion in Pharmacology, 2009
- TMEM16A, A Membrane Protein Associated with Calcium-Dependent Chloride Channel ActivityScience, 2008
- Expression Cloning of TMEM16A as a Calcium-Activated Chloride Channel SubunitCell, 2008
- Differential effects of cyclic and constant stress on ATP release and mucociliary transport by human airway epitheliaThe Journal of Physiology, 2007
- Physiological Regulation of ATP Release at the Apical Surface of Human Airway EpitheliaJournal of Biological Chemistry, 2006
- Cystic Fibrosis Airway Epithelial Ca2+ SignalingPublished by Elsevier BV ,2005
- Protein Phosphatase 4 Is a Positive Regulator of Hematopoietic Progenitor Kinase 1Published by Elsevier BV ,2004